Glassman Wealth Services Charles River Laboratories International, Inc. Transaction History

Glassman Wealth Services

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$164.52 - $238.84 $4,442 - $6,448	27 Added 128.57%	48 $11,000
Q2 2023 Aug 08, 2023	SELL	$183.71 - $210.25 $551 - $630	-3 Reduced 12.5%	21 $4,000
Q1 2023 May 04, 2023	SELL	$191.89 - $259.92 $39,529 - $53,543	-206 Reduced 89.57%	24 $4,000
Q4 2022 Feb 06, 2023	BUY	$197.11 - $250.07 $41,984 - $53,264	213 Added 1252.94%	230 $50,000
Q3 2022 Nov 09, 2022	SELL	$182.44 - $250.54 $2,189 - $3,006	-12 Reduced 41.38%	17 $3,000
Q2 2022 Aug 04, 2022	BUY	$204.13 - $302.4 $1,837 - $2,721	9 Added 45.0%	29 $6,000
Q1 2022 Apr 14, 2022	SELL	$255.51 - $362.11 $255 - $362	-1 Reduced 4.76%	20 $6,000
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $1,756 - $2,243	5 Added 31.25%	21 $8,000
Q3 2021 Nov 10, 2021	BUY	$372.64 - $458.3 $1,490 - $1,833	4 Added 33.33%	16 $7,000
Q2 2021 Aug 04, 2021	BUY	$294.17 - $371.65 $882 - $1,114	3 Added 33.33%	12 $4,000
Q2 2018 Aug 09, 2018	BUY	$102.37 - $117.25 $614 - $703	6 Added 200.0%	9 $1,000
Q1 2018 May 01, 2018	BUY	$98.19 - $115.2 $294 - $345	3 New	3 $0

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.